Revolution Medicines, Inc. (NASDAQ: RVMD) is now covered by analysts at Bank of America Co.. They set a "neutral" rating on the stock.
Revolution Medicines, Inc. (RVMD)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Revolution Medicines Advances First RAS(ON) Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236GlobeNewswire
- Revolution Medicines To Participate In The 43rd Annual Goldman Sachs Global Healthcare Conference [TheStreet.com]TheStreet.com
- Revolution Medicines to Participate in the 43rd Annual Goldman Sachs Global Healthcare ConferenceGlobeNewswire
- Revolution Medicines initiated at neutral at BofA as candidates still in early stages [Seeking Alpha]Seeking Alpha
- Revolution Medicines, Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/RVMD/price-target/">NASDAQ: RVMD</a>) had its "outperform" rating re-affirmed by analysts at SVB Leerink LLC.MarketBeat
RVMD
Earnings
- 5/9/22 - Beat
RVMD
Sec Filings
- 6/27/22 - Form SC
- 6/22/22 - Form 4
- 6/22/22 - Form 4
- RVMD's page on the SEC website